Andrew V Thillainayagam
Overview
Explore the profile of Andrew V Thillainayagam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shariff M, Gomaa A, Cox I, Patel M, Williams H, Crossey M, et al.
J Proteome Res
. 2011 Feb;
10(4):1828-36.
PMID: 21275434
The advent of metabonomics has seen a proliferation of biofluid profiling studies of patients with hepatocellular carcinoma. The majority of these studies have been conducted in single indigenous populations making...
12.
Mcginty J, Galletly N, Dunsby C, Munro I, Elson D, Requejo-Isidro J, et al.
Biomed Opt Express
. 2011 Jan;
1(2):627-640.
PMID: 21258496
Optical imaging of tissue autofluorescence has the potential to provide rapid label-free screening and detection of surface tumors for clinical applications, including when combined with endoscopy. Quantitative imaging of intensity-based...
13.
Patel M, Shariff M, G Ladep N, Thillainayagam A, Thomas H, Khan S, et al.
J Eval Clin Pract
. 2010 Dec;
18(2):335-42.
PMID: 21114800
Hepatocellular carcinoma (HCC) is the commonest primary hepatic malignancy and the third most common cause of cancer-related death worldwide. Incidence remains highest in the developing world and is steadily increasing...
14.
Sharif A, Williams H, Lampejo T, Khan S, Bansi D, Westaby D, et al.
HPB (Oxford)
. 2010 Jul;
12(6):396-402.
PMID: 20662790
Objectives: Cholangiocarcinoma (CCA) has a poor prognosis and its aetiology is inadequately understood. Magnetic resonance spectroscopy (MRS) of bile may provide insights into the pathogenesis of CCA and help identify...
15.
Mudan S, Giakoustidis A, Thillainayagam A, Jacob J, Stebbing J
Future Oncol
. 2009 Dec;
6(1):177-9.
PMID: 20021217
The quantification of circulating tumor cells has been historically problematic due to the different methods applied to their measurement. Following the development of standardized technology, they are now becoming well-established...
16.
Shariff M, G Ladep N, Cox I, Williams H, Okeke E, Malu A, et al.
J Proteome Res
. 2009 Dec;
9(2):1096-103.
PMID: 19968328
Hepatocellular carcinoma (HCC) is the commonest primary hepatic malignancy worldwide. Current serum diagnostic biomarkers, such as alpha-fetoprotein, are expensive and insensitive in early tumor diagnosis. Urinary biomarkers differentiating HCC from...
17.
Adenugba A, Khan S, Taylor-Robinson S, Cox I, Toledano M, Thillainayagam A, et al.
Chemosphere
. 2009 May;
76(6):841-6.
PMID: 19419750
Background: Polychlorinated biphenyls (PCBs) are anthropogenic, organic compounds. Although banned in the 1970s, PCBs are poorly biodegradable and hence ubiquitous in the environment. They accumulate in adipose tissue and are...
18.
Ariff B, Lloyd C, Khan S, Shariff M, Thillainayagam A, Bansi D, et al.
World J Gastroenterol
. 2009 Mar;
15(11):1289-300.
PMID: 19294758
Improvements in imaging technology allow exploitation of the dual blood supply of the liver to aid in the identification and characterisation of both malignant and benign liver lesions. Imaging techniques...
19.
Khan S, Cox I, Thillainayagam A, Bansi D, Thomas H, Taylor-Robinson S
Eur J Gastroenterol Hepatol
. 2005 Jun;
17(7):733-8.
PMID: 15947550
Objective: Hepatopancreaticobiliary cancers can be difficult to diagnose. Nuclear magnetic resonance (NMR) spectroscopy provides non-invasive information on phospholipid metabolism, and previous studies of liver tissue have highlighted changes in phospholipids...
20.
Hasegawa H, Sandhu G, Thillainayagam A, Strickland N, Taylor-Robinson S
J R Soc Med
. 2005 Feb;
98(2):65-6.
PMID: 15684361
No abstract available.